Summary
In the search for differences between estrogen receptor (ER) α and ERβ, we proved that ERα but not ERβ directly interacts with calmodulin (CaM) through the hinge region. The transcriptional activity of a mutant unable to interact with CaM becomes insensitive to inhibition by CaM antagonists (W7). These residues are acetylated by p300 and substitution of lysine 302 and 303 with other residues enhance ERα-hormone sensitivity, suggesting that ERα acetylation normally suppresses ligand sensitivity. Also, the somatic mutation K303R has been identified in early premalignant breast lesions. ERα K303R normally binds E but shows increased E-induced transcriptional activation and increased proliferation in response to E when transfected into breast cancer cell (BC) lines. Herein, we show that mutations K303R and K303A, render an ERα unable to interact with CaM and therefore insensitive to W7. K303 homodimers and K303 mutant/wt heterodimers show increased sensitivity to E. Contrary to the wt ERα, AP1 transcriptional activity is inhibited by estradiol (E2) and OH-Tamoxifen (OH-TAM) in both K303R and K303A mutants.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Kuiper GG, Enmark E, Pelto-Huikko M, et al (1996) Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 93:5925–5930.
Weihua Z, Saji S, Makinen S, et al (2000) Estrogen receptor (ER) beta, a modulator of ERalpha in the uterus. Proc Natl Acad Sci USA 97:5936–5941.
Gustafsson JA (1999) Novel mechanism of estrogen action. In: Paoleti R, Crosignani PG, Kenemans P, Wenger NK and Jackson AS (eds) Women’s Health and Menopause. Risk Reduction Strategies-Improved Quality of Health, London: Kluver Academ Publishers, 33–38.
Paech K, Webb P, Kuiper GG, et al (1997) Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science 277:1508–1510.
Saville B, Wormke M, Wang F, et al (2000) Ligand-cell and estrogen receptor subtype (alpha/beta)-dependent activation at GC-rich (Spl) promoter elements. J Biol Chem 275:5379–3587.
Srivastava S, Weitzmann MN, Cenci S, et al (1999) Estrogen decreases TNF gene expression by blocking JNK activity and the resulting production of c-Jun and JunD. J Clin Invest 104:503–513.
Sun J, Meyers MJ, Fink BE, et al (1999) Novel ligands that function as selective estrogens or antiestrogens for estrogen receptor-alpha or estrogen receptor-beta. Endocrinology 140:800–804.
Gaido KW, Maness SC, McDonnell DP, et al (2000) Interaction of methoxychlor and related compounds with estrogen receptor alpha and beta, and androgen receptor: structure-activity studies. Mol Pharmacol 58:852–858.
Patrone C, Pollio G, Vegeto E, et al (2000) Estradiol induces differential neuronal phenotypes by activating estrogen receptor alpha or beta. Endocrinology 141:1839–1845.
Castoria G, Migliaccio A, Nola E, et al (1988) In vitro interaction of estradiol receptor with Ca2+-calmodulin. Mol. Endocrinol 2:167–174.
Biswas DK, Reddy PV, Pickard M, et al (1998) Calmodulin is essential for estrogen receptor interaction with its motif and activation of responsive promoter. J Biol Chem 273:33817–33824.
García Pedrero JM, del Rio B, Martínez-Campa C, et al (2002) Calmodulin is a selective modulator of estrogen receptors. Mol Endocrinology 16:947–960.
Wang C, Fu M, Angeletti RH, et al (2001) Direct acetylation of the estrogen receptor alpha hinge region by p300 regulates transactivation and hormone sensitivity. J Biol Chem 276:18375–18383.
Fuqua SA, Wiltschke C, Zhang QX, et al (2000) A hypersensitive estrogen receptor-alpha mutation in premalignant breast lesions. Cancer Res 60:4026–4029.
Tremblay GB, Tremblay A, Labrie F, et al (1999) Dominant activity of activation function 1 (AF-1) and differential stoichiometric requirements for AF-1 and-2 in the estrogen receptor alpha-beta heterodimeric complex. Mol Cell Biol 19:1919–1927.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer Science+Business Media, Inc.
About this chapter
Cite this chapter
Martínez-Campa, C., Zuazua, P., García-Pedrero, J.M., Casado, P., Lazo, P.S., Ramos, S. (2005). Abnormal Properties of Mutants in the Hinge Region of ERα: Implications in Breast Cancer. In: Li, J.J., Li, S.A., Llombart-Bosch, A. (eds) Hormonal Carcinogenesis IV. Springer, Boston, MA. https://doi.org/10.1007/0-387-23761-5_38
Download citation
DOI: https://doi.org/10.1007/0-387-23761-5_38
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-23783-1
Online ISBN: 978-0-387-23761-9
eBook Packages: MedicineMedicine (R0)